%D9%88%D8%B1%D9%85_%D8%AC%D9%86%D9%8A%D8%A8_%D8%A7%D9%84%D8%B9%D9%82%D8%AF%D8%A9_%D8%A7%D9%84%D8%B9%D8%B5%D8%A8%D9%8A%D8%A9ParagangliomaCategory:ParagangliomaParagangliomParagangliomParagangliomaParaganglioma_carot%C3%ADdeo%D9%BE%D8%A7%D8%B1%D8%A7%DA%AF%D8%A7%D9%86%DA%AF%D9%84%DB%8C%D9%88%D9%85%D8%A7ParaganglioomaParagangliomeParaganglioma%D0%9F%D0%B0%D1%80%D0%B0%D0%B3%D0%B0%D0%BD%D0%B3%D0%BB%D0%B8%D0%BE%D0%BC%D0%B0ParaganglioomPrzyzwojakParagangli%C3%B3m%D0%9F%D0%B0%D1%80%D0%B0%D0%B3%D0%B0%D0%BD%D0%B3%D0%BB%D1%96%D0%BE%D0%BC%D0%B0Q581592
about
sameAs
A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney CancerGenetic Analysis of Pheochromocytomas, Paragangliomas and Associated ConditionsVorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord TumorsPhase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Metastatic, Recurrent or Primary Unresectable Pheochromocytoma/ParagangliomaLinsitinib in Treating Patients With Gastrointestinal Stromal TumorsStereotactic Body Radiotherapy for Spine TumorsPazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or ParagangliomaPembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are MetastaticLu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ ParagangliomaCompassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine TumorsFirst International Randomized Study in Malignant Progressive Pheochromocytoma and ParagangliomaFamilial Investigations of Childhood Cancer Predisposition18F-FDOPA PET in Neuroendocrine TumoursRAD001 in Pheochromocytoma or Nonfunctioning Carcinoid131-I-MIBG Therapy for Refractory Neuroblastoma and Metastatic Paraganglioma/PheochromocytomaExpanded Access Protocol Using I131-MIBGDovitinib in Neuroendocrine TumorsDosimetry Guided PRRT With 177Lu-DOTATATE in ChildrenPhase I Trial of Vandetanib Combined With 131I-mIBG to Treat Patients With Advanced Phaeochromocytoma and ParagangliomaComparison of Diagnostic Performances of 68Ga-DOTATATE PET-CT and 18F-FDOPA PET-CT in Paragangliomas and Pheochromocytomas EvaluationGA-69 DOTA-TATE Imaging of Somatostatin R+ MalignanciesCixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine CarcinomaTemsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsSpecificity of Elevated Plasma EM66 Levels in PheochromocytomaA Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related TumorsA Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/ParagangliomaMulticenter Pheochromocytoma and Paraganglioma EvaluationDOTATOC PET/CT for Imaging NET PatientsCabozantinib S-malate in Treating Patients With Metastatic Pheochromocytomas or Paragangliomas That Cannot Be Removed by SurgeryStereotactic Body Radiotherapy for Head and Neck TumorsStudy Of Sunitinib In Patients With Recurrent Paraganglioma/PheochromocytomaContent Validation of Quality of Life and Symptom Questionnaires for Pheochromocytoma and ParagangliomaPhase 1 Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/ParagangliomaULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic CarcinoidHereditary Paraganglioma: Evaluation of Screening Methods to Detect Tumors in SDH Positive CarriersPreoperative Alpha Blockade for PheochromocytomaDynamic Whole Body Positron Emission Tomography/Computed Tomography ImagingLAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA)Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma
P1050
15 YEARS OF PARAGANGLIOMA: Clinical manifestations of paraganglioma syndromes types 1-5Primary Pulmonary Paraganglioma: A Case Report and Review of LiteratureRetroperitoneal paraganglioma: report of a case and literature reviewPheochromocytoma and paraganglioma: imaging characteristicsHead and neck paragangliomas: clinical and molecular genetic classificationPrimary pancreatic paraganglioma: a case report and literature reviewMalignant extra-adrenal pancreatic paraganglioma: case report and literature reviewMolecular markers of paragangliomas/pheochromocytomasUrinary bladder malignant paraganglioma with vertebral metastasis: a case report with literature review.Recent advances in the genetics of SDH-related paraganglioma and pheochromocytomaPrimary retroperitoneal paraganglioma simulating a pancreatic mass: a case report and review of the literature.Malignant paraganglioma of the mesentery: a case report and review of literature.Pancreatic gangliocytic paraganglioma harboring lymph node metastasis: a case report and literature review.Perioperative management of paraganglioma and catecholamine-induced cardiomyopathy in child- a case report and review of the literature.Clinical and Molecular Features of Renal and Pheochromocytoma/Paraganglioma Tumor Association Syndrome (RAPTAS): Case Series and Literature Review.WNT signaling, the development of the sympathoadrenal-paraganglionic system and neuroblastoma.Metabolic implications of hypoxia and pseudohypoxia in pheochromocytoma and paraganglioma.Efficacy and Safety of High-Specific-Activity I-131 MIBG Therapy in Patients with Advanced Pheochromocytoma or ParagangliomaNew insights on the pathogenesis of paraganglioma and pheochromocytomaPrimary malignant tumors of the adrenal glandsF-FDOPA PET/CT Combined with MRI for Gross Tumor Volume Delineation in Patients with Skull Base ParagangliomaIncreased Mortality in but Not in Pathogenic Variant CarriersPheochromocytoma in pregnancy: cesarean section and adrenalectomyRectal ParagangliomaLaparoscopic resection of interaortocaval paraganglioma in left lateral decubitus (with video)[Pediatric pheochromocytoma and paraganglioma: an update]Concomitant paraganglioma and thyroid carcinoma: A case reportMultimodality imaging of paragangliomas of the head and neckParaganglioma of the tongue with SDHB gene mutation in a patient with Graves' diseaseResection of a functioning intrapericardial paraganglioma associated with succinate dehydrogenase B mutationA Developmental Perspective on Paragangliar TumorigenesisConcomitant primary ovarian paraganglioma neuroendocrinal differentiated urothelial tumor in a BOTOX-injected bladder: A case reportParaganglioma presenting as stress cardiomyopathy: case report and literature reviewClinical, Diagnostic, and Treatment Characteristics of -Related Metastatic Pheochromocytoma and ParagangliomaMultifocal paraganglioma, mycosis fungoides, and monoclonal B-cell lymphocytosis in association with mutationConcomitant Lu-DOTATATE and capecitabine therapy in malignant paragangliomasThe Value of Histological Algorithms to Predict the Malignancy Potential of Pheochromocytomas and Abdominal Paragangliomas-A Meta-Analysis and Systematic Review of the LiteraturePathology of the carotid spaceAcute Paraplegia Revealing a Hemorrhagic Cauda Equina Paragangliomas
P921
Q61908775-15A6C127-750A-4996-90A8-C913F87C6437Q61909293-23163DFD-EE57-4202-94F7-DA2C1498A0D6Q61938124-3536C289-5620-48BA-A8F9-2A5CBA8D0911Q61975581-28875FDE-93C1-43D1-8D02-766B208C62BDQ63316747-3E2E676B-3FFE-4E6C-ACAF-65EAC900FC79Q63335811-50AF2DE8-D903-4D86-BC7E-CEE04372E9ACQ63338124-22C1B32A-FC6B-4B69-B9F3-1BE5E2C6A5FBQ63578126-B108D20B-CCC6-4F99-8CE7-BAE654D2852CQ63807728-E133729A-D750-4290-9689-757288C4312BQ63812534-2DBB5416-068F-4378-BFBF-70F4423F9B9DQ63812835-83C95ECD-5947-41ED-A618-70D1123FA5ACQ63813059-798083E3-DD89-48C6-8DF2-65976A09B3C6Q63813116-8EAC5AB3-EFFA-4FF8-AFD6-4B43156487CFQ63813410-A4E6CE9C-68BB-494E-883C-3C855299E604Q63829179-643A4517-7ED8-47D4-9B73-708D27988C66Q63833534-AC6A45A7-DB35-4994-8ECB-D6B45FDC9C94Q63843997-BF1C6822-F8EB-42E1-9799-F88E5BFE1C22Q64030464-8038C5D4-3CD1-4278-920D-D5A4B35FB3D0Q64189709-CC66D0F1-2291-4B10-88F7-10B870F728CAQ64354820-60D15186-4E90-4D11-A699-EFCF5E3316DBQ64607996-00BE92D6-A1E4-4EBA-B370-2FD1B26AFA86Q64610987-1B25E3B6-DDBA-4B20-BEEB-644055A0474BQ64652728-0AD89A1D-0B4A-488B-A09A-53CEFD141999Q64654813-E00D3115-1335-41EE-8179-6EFF77EEB72FQ64660101-196478B9-8BE6-4448-ABE9-DD117991A0D5Q64660387-EACB2F0B-BC69-48E9-9A03-286F754A68D0Q64680760-B1ED1B0E-9E62-4BFC-A2B1-F7D4B79C8CEDQ64789278-3419F07B-8BD4-42B8-815F-D0214FBB3F1BQ64794934-4343E73B-03F0-44BA-97DD-F5599091E0D1Q65351071-807A856C-993C-4FC6-9958-347D2B553557Q65376199-69063A3C-DF43-4839-B2C6-367BC034A68DQ65377231-14EA9348-3AA4-4674-AC15-763BAA79834EQ65378652-1B4F02D2-C11E-4A92-A939-95C4A0C2F510Q65384653-BC65C6A6-AB42-4AF1-BA6C-975291C84FFDQ65389414-B197F541-D2E3-4EA4-99C6-A12E48CA05CCQ65546975-6316BB4B-AA44-4A27-AA4C-E7B733F9ABD4Q66043117-C0DC9804-3ED8-4B36-9BB7-685EA84505BEQ66062010-01922E5F-37AC-4322-8FFD-B3EACD752C1EQ66066750-1F1F9B8F-715F-462E-92AA-AD5284310280Q66068112-2AE87214-6FF8-4421-A4D6-BBD33DBD807F
P1050
Q53996610-dd2f9754-4374-3538-baa7-af31ad78c32bQ54932022-dcd7d1aa-4a34-c1d9-f4f0-7ed7e3e876a0Q54960986-a1b3b5b6-44dc-f834-679c-1ff3b5bdd634Q55093109-3ca5d4b4-4f77-265c-f238-987b857a6a29Q55789474-ce186e35-4715-c9f7-bc0d-52b1d96bf5c5Q55789483-5e731a33-4492-e921-ff35-f781f022c2e8Q55950297-6de934b6-4389-6c5b-5426-62de60c80353
P279
Q26798384-73DB965F-45F8-4FCD-93FF-DEE8EFAD7867Q26801124-72552A31-AB26-4346-9770-FA0F4F38F550Q26853169-A50D701C-1EAD-4C3B-88A6-70A5EC5CC0F4Q27008260-F5F94D4D-3653-41DC-B0D5-A0DBFCE6AF16Q27016092-1E8D4FA9-A948-469E-95B7-A6196D6F7573Q28074320-6D7A59FA-6539-4F32-820B-388B554B6C18Q33589290-245C21E1-D40B-4B84-9E6C-AC295D709080Q33649025-C1C67C21-F646-4A15-ABE9-B88A06BA6941Q37353941-59D00909-925D-4EEE-91FB-BF928F533568Q37809993-985652EC-2D33-4080-BC37-CE70F3C41509Q37824261-D821A03D-8952-459D-820E-2319BD6C3600Q37987635-762D28B6-7CBA-47AA-A60B-643D75489465Q41213228-29B58806-4B85-4E62-9BC8-9884A9955EF4Q42682330-633B1569-C5C1-4254-8078-9E2318FC9CE8Q47143784-B8253C32-6C5B-4436-BD4A-0EC090E1668BQ47618158-EDB6A18F-82A7-4687-BD44-D4C98AC3835FQ49948832-D573DBB1-8355-41E2-B28B-99183B82CEF1Q57022343-12CA06B4-8215-4886-9F8E-4BACC1EB2EBBQ57821959-F6C125EA-33E8-4D10-BE40-7213D5ADCF3DQ59806698-A96CDC5E-A5C5-48FF-919A-3043BDB15611Q61800510-D35E366F-51D9-449F-85CF-7FE956B7A8CAQ61813962-2A856593-CB47-475A-BD58-9A2F8801CAD9Q61845540-CB2FFDD7-C67C-4424-9D04-AEA6FD07A031Q64043528-19B76E99-A075-43AA-A74C-4A6162FE4B88Q64046762-44976572-ACA6-46FC-B5E9-5CDE7385C3C4Q64049826-F741FF39-EEAA-4449-82F6-6F6DDA1DD828Q64060350-CC64E887-8406-46CE-89AD-62B6B6728FC1Q64068008-F269F5F7-3314-4D81-929B-B5ADB5C4CBB9Q64071950-E90D2642-DDA8-4AD1-952B-1268EB0089F0Q64097295-8954A3F1-43CF-47FA-84CF-0D671CE6A57AQ64099571-57B91975-06FB-4AB4-BDCF-79DF9DDAFF84Q64107606-7F1FDE75-C2AA-4D66-84FC-B864E037F828Q64107833-5E0C1661-A105-4EF7-8EFE-69A8FF338ED3Q64110942-AAF054E7-423B-4D45-82EC-04DC61061CA4Q64112376-63AD14C2-52E7-4C77-8C6E-821FE135FD99Q64232680-BC97B9EB-BE8A-423E-8903-8F9466261123Q64245118-0502C007-AEF9-43CA-A61B-BFC143D14D1EQ64247611-D0FC9343-4F42-4FA6-BEDA-85691EFC23A6Q64264532-B40C3096-CD7E-4695-AA80-CD09AD82C253
P921
description
Human disease
@en
Krankheit
@de
Tumori che insorgono dai parag ...... omocitoma) ed extra-surrenalic
@it
nádorové onemocnění
@cs
مرض يصيب الإنسان
@ar
name
Paragangliom
@cs
Paragangliom
@de
Paraganglioma carotídeo
@es
Paragangliome
@fr
Paraganglioom
@nl
Paraganglióm
@sk
Przyzwojak
@pl
paraganglioma
@ca
paraganglioma
@en
paraganglioma
@it
type
label
Paragangliom
@cs
Paragangliom
@de
Paraganglioma carotídeo
@es
Paragangliome
@fr
Paraganglioom
@nl
Paraganglióm
@sk
Przyzwojak
@pl
paraganglioma
@ca
paraganglioma
@en
paraganglioma
@it
altLabel
Neoplasm of Paraganglion
@en
Neoplasm of the Paraganglion
@en
Paraganglioma carotideo
@es
Paraganglioma
@en
Paraganglion Neoplasm
@en
Paraganglion Tumor
@en
Paraganglionic Neoplasm
@en
Paraganglionic Tumor
@en
Tumor of Paraganglion
@en
Tumor of the Paraganglion
@en
prefLabel
Paragangliom
@cs
Paragangliom
@de
Paraganglioma carotídeo
@es
Paragangliome
@fr
Paraganglioom
@nl
Paraganglióm
@sk
Przyzwojak
@pl
paraganglioma
@ca
paraganglioma
@en
paraganglioma
@it
P2293
P2888
P492
P493
P494
P486
P5806
P6366
P646
P1296
P1692
P1748
P1995
P2892
P373
Paraganglioma
P3841
HP:0002668